These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32283882)

  • 1. Role of a berberine-based nutritional supplement in reducing diarrhea in subjects with functional gastrointestinal disorders.
    Di Pierro F; Bertuccioli A; Giuberti R; Saponara M; Ivaldi L
    Minerva Gastroenterol Dietol; 2020 Mar; 66(1):29-34. PubMed ID: 32283882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective analysis of the effects of a highly standardized mixture of Berberis aristata, Silybum marianum, and monacolins K and KA in diabetic patients with dyslipidemia.
    Di Pierro F; Putignano P; Villanova N
    Acta Biomed; 2018 Jan; 88(4):462-469. PubMed ID: 29350661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
    Chen C; Tao C; Liu Z; Lu M; Pan Q; Zheng L; Li Q; Song Z; Fichna J
    Phytother Res; 2015 Nov; 29(11):1822-7. PubMed ID: 26400188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of berberine in the gastrointestinal tract - a review of actions and therapeutic implications.
    Chen C; Yu Z; Li Y; Fichna J; Storr M
    Am J Chin Med; 2014; 42(5):1053-70. PubMed ID: 25183302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tree Turmeric: A Super Food and Contemporary Nutraceutical of 21st Century - A Laconic Review.
    Bhasin J; Thakur B; Kumar S; Kumar V
    J Am Nutr Assoc; 2022; 41(7):728-746. PubMed ID: 34757887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Episodic nature of symptoms in irritable bowel syndrome.
    Palsson OS; Baggish J; Whitehead WE
    Am J Gastroenterol; 2014 Sep; 109(9):1450-60. PubMed ID: 24980882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.
    Basseri RJ; Kunkel D; Low K; Conklin JL; Pimentel M
    J Clin Gastroenterol; 2011 Oct; 45(9):790-3. PubMed ID: 21301356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Berberine Improves Intestinal Motility and Visceral Pain in the Mouse Models Mimicking Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Symptoms in an Opioid-Receptor Dependent Manner.
    Chen C; Lu M; Pan Q; Fichna J; Zheng L; Wang K; Yu Z; Li Y; Li K; Song A; Liu Z; Song Z; Kreis M
    PLoS One; 2015; 10(12):e0145556. PubMed ID: 26700862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
    Dove LS; Lembo A; Randall CW; Fogel R; Andrae D; Davenport JM; McIntyre G; Almenoff JS; Covington PS
    Gastroenterology; 2013 Aug; 145(2):329-38.e1. PubMed ID: 23583433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of a nutraceutical supplement containing highly standardized perilla and ginger extracts in patients with functional dyspepsia.
    Di Pierro F; Giovannone M; Saponara M; Ivaldi L
    Minerva Gastroenterol Dietol; 2020 Mar; 66(1):35-40. PubMed ID: 32283883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herbal formula improves upper and lower gastrointestinal symptoms and gut health in Australian adults with digestive disorders.
    Ried K; Travica N; Dorairaj R; Sali A
    Nutr Res; 2020 Apr; 76():37-51. PubMed ID: 32151878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial of berberine in acute watery diarrhoea.
    Khin-Maung-U ; Myo-Khin ; Nyunt-Nyunt-Wai ; Aye-Kyaw ; Tin-U
    Br Med J (Clin Res Ed); 1985 Dec; 291(6509):1601-5. PubMed ID: 3935203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome.
    Camilleri M; Chey WY; Mayer EA; Northcutt AR; Heath A; Dukes GE; McSorley D; Mangel AM
    Arch Intern Med; 2001 Jul; 161(14):1733-40. PubMed ID: 11485506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of inactivated Lactobacillus LB fermented culture medium on symptom severity: observational investigation in 297 patients with diarrhea-predominant irritable bowel syndrome.
    Tarrerias AL; Costil V; Vicari F; Létard JC; Adenis-Lamarre P; Aisène A; Batistelli D; Bonnaud G; Carpentier S; Dalbiès P; Ecuer S; Etienne J; Fantoli M; Grunberg B; Lannoy P; Lapuelle J; Margulies A; Neumeier M; Rouillon JM; Schmets L; Pingannaud MP; Coulom P; Kholer F; Canard JM
    Dig Dis; 2011; 29(6):588-91. PubMed ID: 22179215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the Management of Diarrhea-Predominant Irritable Bowel Syndrome: Focus on Rifaximin and Eluxadoline.
    Rivkin A; Rybalov S
    Pharmacotherapy; 2016 Mar; 36(3):300-16. PubMed ID: 26971716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine prevents stress-induced gut inflammation and visceral hypersensitivity and reduces intestinal motility in rats.
    Yu ZC; Cen YX; Wu BH; Wei C; Xiong F; Li DF; Liu TT; Luo MH; Guo LL; Li YX; Wang LS; Wang JY; Yao J
    World J Gastroenterol; 2019 Aug; 25(29):3956-3971. PubMed ID: 31413530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of diarrhea-predominant irritable bowel syndrome with mesalazine and/or Saccharomyces boulardii.
    Bafutto M; Almeida JR; Leite NV; Costa MB; Oliveira EC; Resende-Filho J
    Arq Gastroenterol; 2013; 50(4):304-9. PubMed ID: 24474234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome.
    Kane JS; Ford AC
    Expert Rev Gastroenterol Hepatol; 2016; 10(4):431-42. PubMed ID: 26753693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.
    Halmos EP; Power VA; Shepherd SJ; Gibson PR; Muir JG
    Gastroenterology; 2014 Jan; 146(1):67-75.e5. PubMed ID: 24076059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of alosetron on bowel urgency and global symptoms in women with severe, diarrhea-predominant irritable bowel syndrome: analysis of two controlled trials.
    Lembo AJ; Olden KW; Ameen VZ; Gordon SL; Heath AT; Carter EG
    Clin Gastroenterol Hepatol; 2004 Aug; 2(8):675-82. PubMed ID: 15290660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.